Skylands Capital, LLC Cytosorbents Corp Transaction History
Skylands Capital, LLC
- $660 Million
- Q4 2024
A detailed history of Skylands Capital, LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, Skylands Capital, LLC holds 2,781,622 shares of CTSO stock, worth $3.03 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
2,781,622
Previous 2,755,427
0.95%
Holding current value
$3.03 Million
Previous $4.13 Million
39.44%
% of portfolio
0.38%
Previous 0.6%
Shares
30 transactions
Others Institutions Holding CTSO
# of Institutions
58Shares Held
15.7MCall Options Held
16KPut Options Held
0-
Avenir Corp Washington, DC3.09MShares$3.37 Million0.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$2.13 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.68MShares$1.83 Million0.0% of portfolio
-
Sargent Investment Group, LLC1.25MShares$1.36 Million0.18% of portfolio
-
Granahan Investment Management, LLC Waltham, MA1.2MShares$1.31 Million0.05% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $47.5M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...